Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDNeogenomics Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 6 | -$0.16 | $0.10 | $0.01 |
| Q2 2026 | 7 | $0.02 | $0.04 | $0.03 |
| Q3 2026 | 7 | $0.03 | $0.08 | $0.05 |
| Q4 2026 | 3 | $0.08 | $0.08 | $0.08 |
| Q1 2027 | 3 | $0.07 | $0.07 | $0.07 |
| Q2 2027 | 2 | $0.08 | $0.08 | $0.08 |
| Q3 2027 | 2 | $0.09 | $0.09 | $0.09 |
| Q4 2027 | 2 | $0.13 | $0.13 | $0.13 |
| Q1 2028 | 3 | $0.12 | $0.13 | $0.13 |
| Q2 2028 | 6 | $0.11 | $0.11 | $0.11 |
| Q3 2028 | 5 | $0.12 | $0.13 | $0.12 |
| Q4 2028 | 5 | $0.16 | $0.16 | $0.16 |
Neogenomics Inc. Earnings Date And Information
Neogenomics Inc. last posted its earnings results on Tuesday, April 28th, 2026. The company reported $0.01 earnings per share for the quarter, topping analysts' consensus estimates of $0.00578 by $0.00422. The company had revenue of 186.67 M for the quarter and had revenue of 727.33 M for the year. Neogenomics Inc. has generated $-4 earnings per share over the last year ($-4.2 diluted earnings per share) and currently has a price-to-earnings ratio of -2.92. Neogenomics Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Neogenomics Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 04/28/2026 | Q1 2026 | $0.01 | -$0.65 | -0.66 | $184.54 M | $186.67 M |
| 02/17/2026 | Q4 2025 | $0.04 | -$0.38 | -0.42 | $188.50 M | $190.17 M |
| 10/28/2025 | Q3 2025 | $0.02 | -$1.05 | -1.07 | $183.73 M | $187.80 M |
| 07/29/2025 | Q2 2025 | $0.03 | -$1.75 | -1.78 | $182.65 M | $181.33 M |
| 04/29/2025 | Q1 2025 | -$0.02 | -$1.00 | -0.98 | $170.58 M | $168.04 M |
| 02/18/2025 | Q4 2024 | $0.03 | -$0.60 | -0.63 | $173.19 M | $172.00 M |
| 11/05/2024 | Q3 2024 | $0.01 | -$0.70 | -0.71 | $167.00 M | $167.82 M |
| 07/30/2024 | Q2 2024 | N/A | -$0.75 | N/A | $161.82 M | $164.50 M |
| 04/30/2024 | Q1 2024 | -$0.01 | -$1.05 | -1.04 | $149.85 M | $156.24 M |
| 02/20/2024 | Q4 2023 | $0.01 | -$0.55 | -0.56 | N/A | $155.55 M |
| 11/06/2023 | Q3 2023 | -$0.07 | -$0.75 | -0.68 | N/A | $151.95 M |
| 08/08/2023 | Q2 2023 | -$0.10 | -$0.95 | -0.85 | N/A | $146.92 M |
| 05/09/2023 | Q1 2023 | N/A | -$1.25 | N/A | N/A | $137.22 M |
| 02/24/2023 | Q4 2022 | N/A | -$0.90 | N/A | N/A | $138.71 M |
| 11/08/2022 | Q3 2022 | -$0.19 | -$1.50 | -1.31 | N/A | $128.78 M |
| 08/09/2022 | Q2 2022 | -$0.22 | -$1.40 | -1.18 | N/A | $125.07 M |
| 05/09/2022 | Q1 2022 | N/A | -$2.00 | N/A | N/A | $117.17 M |
| 02/25/2022 | Q4 2021 | N/A | -$1.70 | N/A | N/A | $125.73 M |
| 11/04/2021 | Q3 2021 | -$0.08 | -$0.85 | -0.77 | N/A | $121.34 M |
| 08/09/2021 | Q2 2021 | N/A | $3.20 | N/A | N/A | $121.72 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Neogenomics Inc. Earnings: FAQ's
In the previous quarter, Neogenomics Inc. (:NEO) reported $0.01 earnings per share (EPS) to beat the analysts' consensus estimate of $0.00578 by $0.00422.
The conference call for Neogenomics Inc.'s latest earnings report can be listened to online.
The conference call transcript for Neogenomics Inc.'s latest earnings report can be read online.
Neogenomics Inc. (:NEO) has a recorded annual revenue of $727.33 M.
Neogenomics Inc. (:NEO) has a recorded net income of $-108,025,000.Neogenomics Inc. has generated $-4.2 earnings per share over the last four quarters.
Neogenomics Inc. (:NEO) has a price-to-earnings ratio of -2.92 and price/earnings-to-growth ratio is 0.1.